focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Share News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.50
Bid: 61.00
Ask: 62.00
Change: -0.50 (-0.81%)
Spread: 1.00 (1.639%)
Open: 61.50
High: 61.50
Low: 61.50
Prev. Close: 62.00
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Treatt revenue falls; Secure Trust profit picks up

Thu, 25th Jan 2024 20:21

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Secure Trust Bank PLC - Solihull, England-based provider of savings accounts and lending services - Continues to trade in line with management expectations in the fourth quarter ended December 31, with a significant increase to year-on-year underlying pretax profit and impairments. Net lending grew by around 14% in the year to GBP3.3 billion, a significant step towards the GBP4 billion ambition. Says all four specialist lending businesses delivered record levels of new lending in 2023. Company remains on track to deliver GBP5 million in annualised savings from cost optimisation programme in 2024.

----------

Treatt PLC - manufacturer and supplier of extracts and ingredients for the beverage, flavour and fragrance industries - Trading update ahead of annual general meeting. Revenue performance in first quarter, typically the quietest quarter, saw a decline year on year as anticipated, reflecting the impact of destocking. Reports encouraging signs that destocking trends are reversing, expects customer demand to return to more normal levels in second quarter. On track for further improvement in net debt in line with expectations.

----------

Mortgage Advice Bureau Holdings PLC - Reports trading was better than anticipated in the fourth quarter to December 31. Expects to report an adjusted pretax profit slightly ahead of current market consensus.

----------

Tissue Regenix Group PLC - Leeds, England-based medical device company - Trading update for year ended December 31. Total revenue expected to increase by 21% to USD29.5 million from USD24.5 million, ahead of expectations. An adjusted earnings before interest, tax, depreciation and amortisation profit is expected for 2023, ahead of expectations. Company says trading was very strong, with growth achieved across all three segments of the business. Continues to see robust demand for its portfolio of products. Says revenue growth in 2023 was driven by the BioRinse segment. Expects positive trading conditions to remain through 2024.

----------

Novacyt SA - Eastleigh-based biotechnology group focused on clinical diagnostics - Expects revenue for 2023 to total around GBP11.6 million, in line with guidance. 2022 revenue was GBP21.0 million. Cash position at December 31 was GBP44.1 million, down from GBP81.7 million, reflecting the acquisition of Yourgene. Remains debt free.

----------

Aquis Exchange PLC - London-based financial markets operator, including pan-European equities trading platform Aquis Markets and UK growth-company market Aquis Stock Exchange - Expects to report performance for full-year 2023 in line with board expectations. Sees revenue up 12% to GBP22.6 million from GBP20.1 million in 2022, pretax profit up 16% to GBP5.2 million from GBP4.5 million and cash up 4% to GBP14.8 million from GBP14.2 million. For the Data division, revenue is up 23%. Technologies revenue is up 19%, while Markets is up 7%.

----------

Epwin Group PLC - Solihull, England-based building products' manufacturer - Expects full-year 2023 underlying operating profit to be towards upper end of market expectations. This would be a significant increase over financial 2022. Says trading remained resilient through to the end of the year. Trading in the first weeks of 2024 has been in line with the expectations.

----------

Animalcare Group PLC - trading update for year to December 31. Expects full year revenue to be around GBP74.4 million, up 4% from GBP71.6 million the year prior. Anticipates underlying earnings before interest, tax, amortisation and depreciation will be in line with market expectations and at least in line with 2022's GBP13.1 million. Headline revenue benefited from strong growth in the Companion Animals oral health range, notably Plaqtiv+, demand for Danilon in Equine and continuing momentum of the Identicare pet microchipping and consumer-focused services business.

----------

Empresaria Group PLC - Crawley, England-based recruitment company - Net fee income drops 12% to GBP57.5 million, down 11% in constant currency. Expects adjusted pretax profit to be at the top end of the range guided to in November, of GBP3.0 million to GBP3.5 million. Offshore Services continues to perform well, with net fee income up 4% despite challenging market conditions. Explains permanent placement activity has been most significantly impacted with net fee income down 25% year-on-year. Temporary and contract net fee income is down 10%.

----------

Personal Group Holdings PLC - Milton Keynes-based employee benefits and services provider - Predicts revenue of GBP103 million, up from GBP86.7 million in 2022 and adjusted earnings before interest, tax, depreciation and amortisation of GBP8.0 million, up from GBP6.0 million the year before, in line with market expectations. Total recurring revenue increases by 14% to GBP38.3 million, insurance annualised premium income rises 13% to GBP31.6 million. Trading in the first few weeks of 2024 has been positive, reinforcing confidence in ongoing delivery moving forward.

----------

Strix Group PLC - Isle of Man-based provider of kettle safety controls - Reports adjusted pretax profit of GBP20.6 million on a constant currency and GBP20.1 million on a reported basis. Demand for kettle controls in the key export regulated markets remains subdued, and whilst it has delivered quarter on quarter recovery during 2023 which it expects to continue, it remains around 20% lower by volume than 2021 and the recovery has been slower than anticipated. Strix also announces appointment of Clare Foster as chief financial officer. Says Foster will join Strix on February 1 and formally take office on April 2.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
11 Nov 2019 10:32

Tissue Regenix Upbeat On Lender Deal On Loan Covenant Breach Forecast

Tissue Regenix Upbeat On Lender Deal On Loan Covenant Breach Forecast

Read more
17 Oct 2019 09:43

Tissue Regenix Expects Sales Disappointment Amid Output Boost Delay

Tissue Regenix Expects Sales Disappointment Amid Output Boost Delay

Read more
17 Oct 2019 08:03

Tissue Regenix warns of lower revenues and EBITDA

(Sharecast News) - Regenerative medical devices group Tissue Regenix warned on Thursday that full-year revenues would be roughly 15-20% lower than anticipated after a delay in bringing increased manufacturing capabilities onstream.

Read more
3 Oct 2019 11:48

Tissue Regenix Extends DermaPure Product Line For Surgical Markets

Tissue Regenix Extends DermaPure Product Line For Surgical Markets

Read more
3 Oct 2019 08:29

Tissue Regenix extends dCELL technology with new DermaPure product

(Sharecast News) - Regenerative medical devices company Tissue Regenix Group announced the launch of a product line extension 'DermaPure Non-Oriented' on Thursday, which it said was specifically tailored for the surgical and trauma markets, further expanding the reach of its flagship 'dCELL' technology product, 'DermaPure'.

Read more
10 Sep 2019 11:26

Tissue Regenix Narrows Interim Loss And Targets Geographic Expansion

(Alliance News) - Tissue Regenix Group PLC on Tuesday said it narrowed its first-half losses as sales rose and expenses were trimmed.In the six months to June 30, group sales, essentially a

Read more
28 Aug 2019 16:00

Mike Barker installed as finance chief at Tissue Regenix

(Sharecast News) - Regenerative medical devices company Tissue Regenix Group announced the appointment of Mike Barker as its chief financial officer on Wednesday.

Read more
28 Aug 2019 13:42

Tissue Regenix Appoints Mike Barker As New Finance Boss

(Alliance News) - Medical devices firm Tissue Regenix Group PLC said Wednesday it appointed Mike Barker as its new chief financial officer with immediate effect.Barker - a chartered - has a

Read more
15 Aug 2019 12:55

Tissue Regenix Expands Manufacturing Capacity To Meet Increased Demand

(Alliance News) - Tissue Regenix Group PLC on Thursday said it has signed a 10-year lease agreement to expand the processing capacity at its manufacturing base in San Antonio, Texas.The the

Read more
15 Aug 2019 09:59

Tissue Regenix signs lease to expand San Antonio facility

(Sharecast News) - Regenerative medical devices company Tissue Regenix Group has signed a 10-year lease agreement on a 21,000 square foot facility, it announced on Thursday, to expand processing capacity at its manufacturing base in San Antonio, Texas.

Read more
1 Aug 2019 15:16

Tissue Regenix Appoints COO Gareth Jones As Interim Chief Executive

(Alliance News) - Tissue Regenix Group PLC said Thursday it has appointed Chief Operating Officer Gareth Jones as interim chief executive with immediate effect.He will be replacing Steve is

Read more
9 Jul 2019 09:26

CORRECT (Jul 8): Woodford Transfers Company Stakes After Omnis Departs

(Correcting that Woodford Investment Management transferred a number of stakes following Omnis's decision. It did not sell these stakes, as was originally reported.)(Alliance News) - of

Read more
20 Jun 2019 16:02

UK Shareholder Meetings Calendar - Next 7 Days

Friday 21 JuneBoohoo GroupGulf KeystoneBH GlobalEJF ResourceSigma

Read more
4 Jun 2019 10:23

Tissue Regenix Reports Strong 2018 Performance; Secures Credit Funding

LONDON (Alliance News) - Medical devices firm Tissue Regenix Group PLC said Tuesday its loss narrowed in 2018, after revenue more than doubled on significant growth in product sales.In a it

Read more
21 May 2019 11:13

Tissue Regenix Chief Executive Couldwell To Return After Medical Leave

LONDON (Alliance News) - Medical devices firm Tissue Regenix Group PLC said on Tuesday that Chief Executive Officer Steve Couldwell will return to his full time duties in June, following a leave a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.